171 related articles for article (PubMed ID: 23100604)
1. The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.
Furuse J; Ishii H; Okusaka T
Jpn J Clin Oncol; 2013 Jan; 43(1):2-7. PubMed ID: 23100604
[TBL] [Abstract][Full Text] [Related]
2. Past and present achievements, and future direction of the Gastrointestinal Oncology Study Group (GIOSG), a Division of Japan Clinical Oncology Group (JCOG).
Boku N
Jpn J Clin Oncol; 2011 Dec; 41(12):1315-21. PubMed ID: 21980051
[TBL] [Abstract][Full Text] [Related]
3. The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.
Iwamoto Y; Tanaka K
Jpn J Clin Oncol; 2012 Jun; 42(6):467-70. PubMed ID: 22628611
[TBL] [Abstract][Full Text] [Related]
4. JCOG Radiation Therapy Study Group: history and achievements.
Ishikura S; Ito Y; Hiraoka M
Jpn J Clin Oncol; 2011 Nov; 41(11):1241-3. PubMed ID: 21980050
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].
Furuse J
Gan To Kagaku Ryoho; 2016 Feb; 43(2):160-4. PubMed ID: 27067680
[TBL] [Abstract][Full Text] [Related]
6. The transition of breast cancer treatment and Japan Clinical Oncology Group research over two decades.
Iwata H
Jpn J Clin Oncol; 2012 Jan; 42(1):14-20. PubMed ID: 22080139
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic neoplasm in 2011: an update.
Saif MW
JOP; 2011 Jul; 12(4):316-21. PubMed ID: 21737886
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
10. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy for gastric cancer--evidence from the world and future strategy in Japan].
Yoshikawa T; Aoyama T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Gan To Kagaku Ryoho; 2012 Jun; 39(6):866-70. PubMed ID: 22705680
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant chemotherapy followed by surgery as standard treatment for stage II + III thoracic esophageal squamous cell carcinoma in Japan].
Sato M; Ando N
Nihon Geka Gakkai Zasshi; 2011 Mar; 112(2):104-10. PubMed ID: 21488343
[TBL] [Abstract][Full Text] [Related]
13. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
Weigt J; Malfertheiner P
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):395-7. PubMed ID: 20678012
[TBL] [Abstract][Full Text] [Related]
15. [The recent progress in chemoradiotherapy of lung cancer].
Ogawara M; Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514
[TBL] [Abstract][Full Text] [Related]
16. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Tahara M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
[TBL] [Abstract][Full Text] [Related]
17. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
Langer F; Helsberg K; Schütte WH; Leschinger MI
Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
[TBL] [Abstract][Full Text] [Related]
18. [Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer].
Ueno H; Okusaka T
Gan To Kagaku Ryoho; 2012 Mar; 39(3):357-63. PubMed ID: 22421761
[TBL] [Abstract][Full Text] [Related]
19. The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG).
Onda T; Konishi I; Yoshikawa H; Kamura T
Jpn J Clin Oncol; 2011 Oct; 41(10):1156-61. PubMed ID: 21890655
[TBL] [Abstract][Full Text] [Related]
20. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]